Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance? is a research paper published in Cancer Drug Resistance (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA188354
National Institutes of Health
Grant: 5R01CA188354-03
Non-peptide proteasome inhibitors as a novel anticancer agent
Fields of Study
Keywords
Sustainable Development Goals